Addressing Unmet Needs in Metastatic Uveal Melanoma
Marlana Orloff, MD
Gregory Daniels, MD, PhD
Jesse Keller, MD
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
A.J. Gelderblom, MD, PhD
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
All Sides of the Joint: Integrated TGCT Care Across Specialties
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
Breaking New Ground in mCRC: Exploring Novel Targets in mCRC
Scott Kopetz, MD, PhD
Cathy Eng, MD, FACP
From Data to Debate: Global Perspectives on HR+/HER2- mBC Care
Komal Jhaveri, MD, FACP
Giuseppe Curigliano, MD, PhD
Cynthia Villarreal-Garza, MD, DSc
Hiraji Iwata, MD, PhD
Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
The Future of Oral SERDs: Combination Strategies
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
Spotlight on Latin America: Closing the Gap
Spotlight on Europe: Adapting the Evidence
CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer
Kathleen Moore, MD, MS
Joyce F. Liu, MD, MPH
MOA: CDH6-Targeted Antibody-Drug Conjugates
Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making
James M. Cleary, MD, PhD
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC
Lauren A. Byers, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.